BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36948989)

  • 21. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
    Mehta RH; Cox M; Smith EE; Xian Y; Bhatt DL; Fonarow GC; Peterson ED;
    Stroke; 2014 Aug; 45(8):2263-9. PubMed ID: 25070958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of related factors of orolingual angioedema after rt-PA intravenous thrombolytic therapy.
    Wang YX; Li YQ; Chen Y; Zhang CH; Dong Z; Wang Z; Zhao SN; Li CH; Zhang PL
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1478-1484. PubMed ID: 29565510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Acute and Chronic Hyperglycemia With Acute Ischemic Stroke Outcomes Post-Thrombolysis: Findings From Get With The Guidelines-Stroke.
    Masrur S; Cox M; Bhatt DL; Smith EE; Ellrodt G; Fonarow GC; Schwamm L
    J Am Heart Assoc; 2015 Sep; 4(10):e002193. PubMed ID: 26408015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Audit report and systematic review of orolingual angioedema in post-acute stroke thrombolysis.
    Lekoubou A; Philippeau F; Derex L; Olaru A; Gouttard M; Vieillart A; Kengne AP
    Neurol Res; 2014 Jul; 36(7):687-94. PubMed ID: 24620962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke.
    Mokin M; Kass-Hout T; Kass-Hout O; Zivadinov R; Mehta B
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):852-9. PubMed ID: 21703878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Taking Warfarin with Subtherapeutic INR.
    Mowla A; Memon A; Razavi SM; Lail NS; Vaughn CB; Mohammadi P; Sawyer RN; Shirani P
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105678. PubMed ID: 33640783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes with IV tenecteplase and IV alteplase for acute ischemic stroke with or without thrombectomy in real-world settings in the United States.
    Qureshi AI; Baskett WI; Bains NK; French BR; Siddiq F; Gomez CR; Shyu CR
    J Stroke Cerebrovasc Dis; 2023 Feb; 32(2):106898. PubMed ID: 36493706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.
    Simão F; Ustunkaya T; Clermont AC; Feener EP
    Blood; 2017 Apr; 129(16):2280-2290. PubMed ID: 28130211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early ST-segment elevation acute myocardial infarction after thrombolytic therapy for acute ischemic stroke: A case report.
    Manea MM; Dragoş D; Stoica E; Bucşa A; Marinică I; Tuţă S
    Medicine (Baltimore); 2018 Dec; 97(50):e13347. PubMed ID: 30557984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use and Outcomes of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients ≥90 Years of Age.
    Arora R; Salamon E; Katz JM; Cox M; Saver JL; Bhatt DL; Fonarow GC; Peterson ED; Smith EE; Schwamm LH; Xian Y; Libman RB
    Stroke; 2016 Sep; 47(9):2347-54. PubMed ID: 27491734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolysis for Ischemic Stroke during Pregnancy: A Case Report and Review of the Literature.
    Tversky S; Libman RB; Reppucci ML; Tufano AM; Katz JM
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):e167-70. PubMed ID: 27523596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Making a case for the right '-ase' in acute ischemic stroke: alteplase, tenecteplase, and reteplase.
    Chester KW; Corrigan M; Schoeffler JM; Shah M; Toy F; Purdon B; Dillon GM
    Expert Opin Drug Saf; 2019 Feb; 18(2):87-96. PubMed ID: 30712409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
    Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
    Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of symptomatic intracranial haemorrhage in patients with an ischaemic stroke with neurological deterioration after intravenous thrombolysis.
    James B; Chang AD; McTaggart RA; Hemendinger M; Mac Grory B; Cutting SM; Burton TM; Reznik ME; Thompson B; Wendell L; Mahta A; Siket M; Madsen TE; Sheth KN; Nouh A; Furie KL; Jayaraman MV; Khatri P; Yaghi S
    J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):866-869. PubMed ID: 29487169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the safety and efficacy of intravenous thrombolysis for acute ischemic stroke patients with a history of intracerebral hemorrhage: a systematic review and meta-analysis.
    Goh S; Tan NHW; Tan CH; Leow AST; Sia CH; Ho AFW; Lim MJR; Yeo LLL; Tan BYQ
    J Thromb Thrombolysis; 2022 Feb; 53(2):485-494. PubMed ID: 34302590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18-64 years in the USA.
    Joo H; Wang G; George MG
    Stroke Vasc Neurol; 2016 Mar; 1(1):8-15. PubMed ID: 27547449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria.
    Murray NM; Ke M; Yee A; Chen C; Wong C; Bedenk A; Fernandes J; Barazangi N; Tong D
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2488-2495. PubMed ID: 31277995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.
    Heuschmann PU; Berger K; Misselwitz B; Hermanek P; Leffmann C; Adelmann M; Buecker-Nott HJ; Rother J; Neundoerfer B; Kolominsky-Rabas PL; ;
    Stroke; 2003 May; 34(5):1106-13. PubMed ID: 12663875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.